Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global health economics and outcomes research (HEOR) industry attained a value of USD 1.23 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 12.5% to reach USD 2.46 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America region has been laying emphasis on the value-based care and excellent results in pharmaceutical research. The United States has active presence of many key players which are involved in drug research and favourable government regulations for HEOR services. These factors have helped North America to emerge as one of the largest regional market for HEOR. Europe is also likely to have substantial growth owing to the higher usage of advanced drugs and treatment methods. The regulations that are supporting the accessibility of the health services in Europe have also helped HEOR services.
Health economics and outcomes research (HEOR) refer to the services utilised by healthcare and pharma businesses in order to find the value, cost and cost-effectiveness of the products or techniques. The healthcare and pharmaceutical companies are able to make more informed strategic decisions for their products with the help of observational data, price comparison and other market indicators.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on drugs, the HEOR industry is divided into:
On the grounds of service, market is segmented into:
The market is divided on the basis of offering into:
The industry finds its end use in the following:
The regional markets for health economics and outcomes research (HEOR) industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The pharmaceutical industry is witnessing rapid growth in the recent years. The increasing drug development is driving the demand for HEOR industry. With development of new drugs in the pharmaceutical industry, there has been a surge in the number of clinical trials required. Health economics and outcomes research help the clinical development by providing valuable information regarding specific drugs such as accessibility to the population and comparative pricing of rival drugs. The price for a new drug developed and revision of prices of existing drugs is done with the aid of HEOR services which is providing impetus to the growth of industry.
The report gives a detailed analysis of the following key players in the health economics and outcomes research (HEOR) market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2020 |
Historical Period | 2017-2021 |
Forecast Period | 2022-2027 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drugs, Service, Offering, End Use, Region |
Breakup by Drugs | Developing Drugs, Approved Drugs |
Breakup by Service | Real World Evidence, Payer Evidence, Pricing and Reimbursement, Epidemiology Studies, Market Access, Others |
Breakup by Offering | Outsourced, In-house |
Breakup by End Use | Healthcare Providers, Government Organizations, Pharma and Biotech Companies, Healthcare Payers, Others |
Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | IQVIA Inc., Medpace, Inc., Certara, Inc., Syneos Health, McKesson Corporation, Optum, Inc, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Health Economics and Outcomes Research (HEOR) Market Analysis
8.1 Key Industry Highlights
8.2 Global Health Economics and Outcomes Research (HEOR) Historical Market (2017-2021)
8.3 Global Health Economics and Outcomes Research (HEOR) Market Forecast (2022-2027)
8.4 Global Health Economics and Outcomes Research (HEOR) Market by Drugs
8.4.1 Developing Drugs
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Approved Drugs
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Health Economics and Outcomes Research (HEOR) Market by Service
8.5.1 Real World Evidence
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Payer Evidence
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Pricing and Reimbursement
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Epidemiology Studies
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Market Access
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Others
8.6 Global Health Economics and Outcomes Research (HEOR) Market by Offering
8.6.1 Outsourced
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 In-house
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.7 Global Health Economics and Outcomes Research (HEOR) Market by End Use
8.7.1 Healthcare Providers
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Government Organizations
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Pharma and Biotech Companies
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Healthcare Payers
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2017-2021)
8.7.4.3 Forecast Trend (2022-2027)
8.8 Global Health Economics and Outcomes Research (HEOR) Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Cost Analysis
13 Procurement Strategy
13.1 Sourcing Model
13.2 Engagement Model
13.3 Pricing Model
14 Billing Rates
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 IQVIA Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Medpace, Inc.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Certara, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Syneos Health
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 McKesson Corporation
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Optum, Inc
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Industry Events and Developments
List of Key Figures and Tables
1. Global Health Economics and Outcomes Research (HEOR) Market: Key Industry Highlights, 2016 and 2026
2. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Drug (USD Billion), 2017-2021
3. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Drug (USD Billion), 2022-2027
4. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Services (USD Billion), 2017-2021
5. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Services (USD Billion), 2022-2027
6. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Offering (USD Billion), 2017-2021
7. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Offering (USD Billion), 2022-2027
8. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by End Use (USD Billion), 2017-2021
9. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by End Use (USD Billion), 2022-2027
10. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Region (USD Billion), 2017-2021
11. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Region (USD Billion), 2022-2027
12. North America Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
13. North America Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Europe Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Europe Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Asia Pacific Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Asia Pacific Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Latin America Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Latin America Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Middle East and Africa Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Middle East and Africa Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Global Health Economics and Outcomes Research (HEOR) Market Structure
In 2020, the global health economics and outcomes research (HEOR) market attained a value of nearly USD 1.23 billion.
The market is projected to grow at a CAGR of 12.5% between 2021 and 2026.
The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 2.46 billion by 2026.
The major drivers of the market include increasing drug development.
The health economics and outcomes research (HEOR) market is being aided by rising awareness about health disorders and the growing population.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Developing and branded drugs are the leading components in the industry.
Real-world evidence, payer evidence, pricing and reimbursement, epidemiology studies, and market access, among others are the leading grounds of service in the industry.
Outsourced and in-house are the leading offerings in the industry.
Healthcare providers, government organisations, pharma and biotech companies, and healthcare payers, among others are the leading end uses in the industry.
The major players in the industry are IQVIA Inc., Medpace, Inc., Certara, Inc., Syneos Health, McKesson Corporation, and Optum, Inc among others.
The global health economics and outcomes research (HEOR) market attained a value of USD 1.3 billion in 2020, driven by increasing drug development. The market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 13%. The market is projected to reach USD 2.75 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its drugs, the health economics and outcomes research (HEOR) industry can be segmented into developing and branded drugs. Based on its ground of services, the health economics and outcomes research (HEOR) industry can be segmented into real-world evidence, payer evidence, pricing and reimbursement, epidemiology studies, and market access, among others. Based on its offerings, the health economics and outcomes research (HEOR) industry can be segmented into outsourced and in-house. On the basis of end uses, the market is divided into healthcare providers, government organisations, pharma and biotech companies, and healthcare payers, among others. The major regional markets for health economics and outcomes research (HEOR) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include IQVIA Inc., Medpace, Inc., Certara, Inc., Syneos Health, McKesson Corporation, and Optum, Inc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.